Introduction: NICE NG18 recommends level 3 carbohydrate counting from diagnosis for CYP diagnosed with Type 1 Diabetes. Our unit introduced in-patient level 3 carb counting from day 1 in 2015 in response to an audit demonstrating sub-optimal control in the first year of treatment.
Methods: We carried out a longitudinal study of HbA1c in paediatric patients during the first year of diagnosis in two time periods, before and after the introduction of carb counting from day 1; December 2012 October 2014 (n=39) and August 2015 August 2017 (n=42).
Results: The mean HbA1c achieved 12 m post diagnosis reduced from 62.9 mmol/mol in the first group to 54.3 mmol/mol in the second group (P=0.0015).
Conclusions: Introduction of immediate level 3 carbohydrate counting from diagnosis was associated with a clinically and statistically significant reduction in mean HbA1c 12 months after diagnosis.
07 - 09 Nov 2018
British Society for Paediatric Endocrinology and Diabetes